Cargando…

Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?

Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gibler, Robert C, Knestrick, Kaelynn E, Reidy, Brooke L, Lax, Daniel N, Powers, Scott W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470380/
https://www.ncbi.nlm.nih.gov/pubmed/36110896
http://dx.doi.org/10.2147/PHMT.S334744
_version_ 1784788829561946112
author Gibler, Robert C
Knestrick, Kaelynn E
Reidy, Brooke L
Lax, Daniel N
Powers, Scott W
author_facet Gibler, Robert C
Knestrick, Kaelynn E
Reidy, Brooke L
Lax, Daniel N
Powers, Scott W
author_sort Gibler, Robert C
collection PubMed
description Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of these headaches. The burden and impact of chronic migraine in the daily lives of children and adolescents is substantial, requiring a holistic, multidisciplinary, and biopsychosocial approach to conceptualization and treatment. The purpose of this review is to provide a comprehensive “2022” overview of acute and preventive treatments for the management of chronic migraine in youth. We first describe diagnostic criteria for chronic migraine and highlight the state of evidence for acute and preventive treatment in children and adolescents. We then discuss emerging treatments currently receiving rigorous clinical research effort, special considerations for the treatment of chronic migraine in children and adolescents, and avenues for improving existing treatments and expanding access to evidence-based care.
format Online
Article
Text
id pubmed-9470380
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-94703802022-09-14 Management of Chronic Migraine in Children and Adolescents: Where are We in 2022? Gibler, Robert C Knestrick, Kaelynn E Reidy, Brooke L Lax, Daniel N Powers, Scott W Pediatric Health Med Ther Review Migraine is a neurological disorder that affects millions of children and adolescents worldwide. Chronic migraine is a subtype of migraine in which patients experience headaches for more days than not each month, with accompanying symptoms of phonophobia, photophobia, nausea or vomiting for most of these headaches. The burden and impact of chronic migraine in the daily lives of children and adolescents is substantial, requiring a holistic, multidisciplinary, and biopsychosocial approach to conceptualization and treatment. The purpose of this review is to provide a comprehensive “2022” overview of acute and preventive treatments for the management of chronic migraine in youth. We first describe diagnostic criteria for chronic migraine and highlight the state of evidence for acute and preventive treatment in children and adolescents. We then discuss emerging treatments currently receiving rigorous clinical research effort, special considerations for the treatment of chronic migraine in children and adolescents, and avenues for improving existing treatments and expanding access to evidence-based care. Dove 2022-09-09 /pmc/articles/PMC9470380/ /pubmed/36110896 http://dx.doi.org/10.2147/PHMT.S334744 Text en © 2022 Gibler et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Gibler, Robert C
Knestrick, Kaelynn E
Reidy, Brooke L
Lax, Daniel N
Powers, Scott W
Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title_full Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title_fullStr Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title_full_unstemmed Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title_short Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?
title_sort management of chronic migraine in children and adolescents: where are we in 2022?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470380/
https://www.ncbi.nlm.nih.gov/pubmed/36110896
http://dx.doi.org/10.2147/PHMT.S334744
work_keys_str_mv AT giblerrobertc managementofchronicmigraineinchildrenandadolescentswherearewein2022
AT knestrickkaelynne managementofchronicmigraineinchildrenandadolescentswherearewein2022
AT reidybrookel managementofchronicmigraineinchildrenandadolescentswherearewein2022
AT laxdanieln managementofchronicmigraineinchildrenandadolescentswherearewein2022
AT powersscottw managementofchronicmigraineinchildrenandadolescentswherearewein2022